In this setting, some benign ovarian tumors such as fibroma/fibrothecoma also enter the differential diagnosis; SF-1 and inhibin, in addition to c-KIT and DOG-1, can be used to differentiate these lesions. This evidence concerns the gene ANO1 and ovarian benign neoplasm.